132 related articles for article (PubMed ID: 28659208)
21. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
Gillet C; Polard E; Mauduit N; Allain H
Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
[TBL] [Abstract][Full Text] [Related]
22. Medical Emergencies Related to Ethanol and Illicit Drugs at an Annual, Nocturnal, Indoor, Electronic Dance Music Event.
Calle P; Sundahl N; Maudens K; Wille SM; Van Sassenbroeck D; De Graeve K; Gogaert S; De Paepe P; Devriese D; Arno G; Blanckaert P
Prehosp Disaster Med; 2018 Feb; 33(1):71-76. PubMed ID: 29284546
[TBL] [Abstract][Full Text] [Related]
23. The prevalence of new psychoactive substances in biological material - a three-year review of casework in Poland.
Adamowicz P; Gieroń J; Gil D; Lechowicz W; Skulska A; Tokarczyk B
Drug Test Anal; 2016 Jan; 8(1):63-70. PubMed ID: 26666629
[TBL] [Abstract][Full Text] [Related]
24. What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties.
Rychert M; Wilkins C
Drug Test Anal; 2016 Aug; 8(8):768-78. PubMed ID: 26857892
[TBL] [Abstract][Full Text] [Related]
25. Mass poisoning with NPS: 2C-E and Bromo-DragonFly.
Iwersen-Bergmann S; Lehmann S; Heinemann A; Schröder C; Müller A; Jungen H; Andresen-Streichert H; Pueschel K; Vidal C; Mercer-Chalmers-Bender K
Int J Legal Med; 2019 Jan; 133(1):123-129. PubMed ID: 29959557
[TBL] [Abstract][Full Text] [Related]
26. Typology of new psychoactive substance use among the general Australian population.
Sutherland R; Peacock A; Roxburgh A; Barratt MJ; Burns L; Bruno R
Drug Alcohol Depend; 2018 Jul; 188():126-134. PubMed ID: 29775956
[TBL] [Abstract][Full Text] [Related]
27. New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review.
Schifano F; Chiappini S; Miuli A; Corkery JM; Scherbaum N; Napoletano F; Arillotta D; Zangani C; Catalani V; Vento A; Pettorruso M; Martinotti G; Massimo DG; Guirguis A
Exp Neurol; 2021 May; 339():113638. PubMed ID: 33571533
[TBL] [Abstract][Full Text] [Related]
28. New and Emerging Illicit Psychoactive Substances.
Graddy R; Buresh ME; Rastegar DA
Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
[TBL] [Abstract][Full Text] [Related]
29. Drivers involved in road traffic accidents in Piedmont Region: psychoactive substances consumption.
Siliquini R; Chiadò Piat S; Gianino MM; Renga G
J Prev Med Hyg; 2007 Dec; 48(4):123-8. PubMed ID: 18557306
[TBL] [Abstract][Full Text] [Related]
30. 3-MeO-PCP intoxication in two young men: First in vivo detection in Italy.
Bertol E; Pascali J; Palumbo D; Catalani V; Di Milia MG; Fioravanti A; Mari F; Vaiano F
Forensic Sci Int; 2017 May; 274():7-12. PubMed ID: 28057371
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans.
Nugteren-van Lonkhuyzen JJ; van Riel AJ; Brunt TM; Hondebrink L
Drug Alcohol Depend; 2015 Dec; 157():18-27. PubMed ID: 26530501
[TBL] [Abstract][Full Text] [Related]
32. New Psychoactive Substances (NPS) - the Hydra monster of recreational drugs.
Helander A; Bäckberg M
Clin Toxicol (Phila); 2017 Jan; 55(1):1-3. PubMed ID: 27549399
[No Abstract] [Full Text] [Related]
33. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs.
Zuba D; Sekuła K
Drug Test Anal; 2013 Aug; 5(8):634-45. PubMed ID: 22936468
[TBL] [Abstract][Full Text] [Related]
34. Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre.
Hondebrink L; Nugteren-van Lonkhuyzen JJ; Van Der Gouwe D; Brunt TM
Drug Alcohol Depend; 2015 Feb; 147():109-15. PubMed ID: 25541244
[TBL] [Abstract][Full Text] [Related]
35. Case series: toxicity from 25B-NBOMe--a cluster of N-bomb cases.
Gee P; Schep LJ; Jensen BP; Moore G; Barrington S
Clin Toxicol (Phila); 2016; 54(2):141-6. PubMed ID: 26621342
[TBL] [Abstract][Full Text] [Related]
36. 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug.
Bersani FS; Corazza O; Albano G; Valeriani G; Santacroce R; Bolzan Mariotti Posocco F; Cinosi E; Simonato P; Martinotti G; Bersani G; Schifano F
Biomed Res Int; 2014; 2014():734749. PubMed ID: 25105138
[TBL] [Abstract][Full Text] [Related]
37. New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe.
Pirona A; Bo A; Hedrich D; Ferri M; van Gelder N; Giraudon I; Montanari L; Simon R; Mounteney J
Int J Drug Policy; 2017 Feb; 40():84-92. PubMed ID: 27956184
[TBL] [Abstract][Full Text] [Related]
38. Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN).
Dines AM; Wood DM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; Sedefov R; Dargan PI;
Clin Toxicol (Phila); 2015 Nov; 53(9):893-900. PubMed ID: 26503789
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Stimulant, Hallucinogen, and Dissociative Substances Detected in Biological Samples of NPS-Intoxicated Patients in Italy.
Papa P; Valli A; Di Tuccio M; Buscaglia E; Brambilla E; Scaravaggi G; Gallo M; Locatelli CA
J Psychoactive Drugs; 2021; 53(3):247-255. PubMed ID: 33470904
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of intoxication with novel psychoactive substance (NPS) in Pomeranian region, from January to July 2015].
Kabata P; Schetz D; Waldman W; Wiergowsk M; Sein Anand J
Przegl Lek; 2015; 72(10):517-21. PubMed ID: 26946558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
